Minoru Shirota
Japanese microbiologist
You can help expand this article with text translated from the corresponding article in Japanese. (August 2019) Click [show] for important translation instructions.
- Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
- Consider adding a topic to this template: there are already 3,705 articles in the main category, and specifying
|topic=will aid in categorization. - Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
- You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is
Content in this edit is translated from the existing Japanese Wikipedia article at [[:ja:代田稔]]; see its history for attribution. - You may also add the template
{{Translated|ja|代田稔}}to the talk page. - For more guidance, see Wikipedia:Translation.
Minoru Shirota | |
|---|---|
 | |
| Born | 代田 稔 (Shirota Minoru) (1899-04-23)23 April 1899 Tatsuoka, Nagano, Japan |
| Died | 10 March 1982(1982-03-10) (aged 82) Tokyo, Japan |
| Occupation | Microbiologist |
| Known for | Invention of Yakult |
Minoru Shirota (代田 稔, Shirota Minoru, April 23, 1899 – March 10, 1982) was a Japanese microbiologist. In the 1930 Shirota identified a strain of lactic acid bacteria that is part of normal gut flora that he originally called Lactobacillus casei Shirota, which appeared to help contain the growth of harmful bacteria in the gut. The strain was later reclassified as Lactobacillus paracasei Shirota.[1]
He founded the company Yakult Honsha in 1935 to sell beverages containing the strain branded Yakult.[2]
He died in Tokyo, Japan in 1982.[citation needed]
References
- ^ EFSA Panel on Dietetic Products, Nutrition and Allergies (October 2010). "Scientific Opinion on the substantiation of a health claim related to Lactobacillus casei strain Shirota and maintenance of the upper respiratory tract defence against pathogens by maintaining immune defences pursuant to Article 13(5) of Regulation (EC) N". EFSA Journal. 8 (10): 1860. doi:10.2903/j.efsa.2010.1860.
Lay summary: Wallop, Harry (20 October 2010). "Probiotic drinks do not aid health, Europe says". The Telegraph. - ^ Caramia, Giuseppe; Silvi, Stefania (2011). "Chapter 1: Probiotics: From the Ancient Wisdom to the Actual Therapeutical and Neutraceutical Perspective". In Malago, Joshua J.; Koninkx, Jos. F.J.G.; Marinsek-Logar, R. (eds.). Probiotic Bacteria and Enteric Infections Cytoprotection by Probiotic Bacteria. Dordrecht: Springer Science & Business Media. p. 6. ISBN 978-9-4007-0386-5.
